Amarantus Bioscience Holdings Inc (AMBS)

[Rotten Johnny]

"It's impossible to project a price target on a penny stock"

Oh really now..............................................

Listen up - Gerald Commissioning, AMBS CEO unequivocally states the following between 08:02 and 08:23 minute marks:

"We think this represents a $300-Mil. opportunity and a potential acquisition because in the diagnostic space, things are usually acquired as a multiple of sales. So if we ramp up to $3, $4, $5, $10-Mil. in sales, you can expect to see a 10 times sales, 15 times sales, or a 20 times sales buy-out of our technology"

So lets see now:

$300-Mil. buyout offer would = $1.33 pps at current O/S

$500-Mil. buyout offer would = $2.23 pps at current O/S

I'd say that bio-research article you trashed is dead on in their math - wouldn't you - as per above???

Algebra 101

Rock On, JP